curve
RDT makes maiden voyage as a Philips company at the Monaco Yacht Show

Press release issued 18th September 2018

Remote Diagnostic Technologies (RDT), provider of best-in-class remote medical devices for luxury yachts and the maritime market, is pleased to announce its attendance at this year’s Monaco Yacht Show, taking place from the 26th to the 29th September, 2018. This is the first time RDT will exhibit to a maritime audience since it became a Philips Company in June 2018.

RDT is well-established in the superyacht arena, where its Tempus IC2, a fully integrated telemedicine solution for non-medical experts, is providing remote medical support and unrivaled telemedicine capability on-board hundreds of superyachts worldwide. The acquisition by the global player Philips acts as a significant endorsement of the capabilities of RDT and its Tempus technology and opens up exciting new possibilities to further develop RDT’s portfolio for the superyacht market going forward.

Medical provisioning on-board superyachts is critical in ensuring passengers and crew receive the best possible care and therefore outcomes. Tempus IC2 is a remote medical monitoring device that enables non-medical personnel to deliver care during medical events by connecting them in real-time to a shore based medical expert. The device measures and relays live vital signs from the scene of the incident so that the experts have access to as much information as they would if they were on-board with the patient. This allows them to make well informed remote treatment decisions, ensuring the most appropriate medical care is provided, potentially saving lives, managing cost and often avoiding the need to return to shore.

RDT will be exhibiting in the PRIVA lounge alongside its trusted partner MedAire. Please contact Roland Archdall, Global Head of Yachting to book an appointment to discuss your on-board medical set-up (rarchdall@rdtltd.com).

For more information on RDT and its solutions for superyacht owners and operators, please visit the website.

 About RDT:

RDT, a Philips company, is a fast growing and customer focused, high-technology medical device business. Specialising in the design, manufacture, sales, marketing and worldwide distribution of best-in-class monitoring and resuscitation solutions. Data & communications is core to all RDT do. With success on a global scale, serving an International customer base – driven and supported by a team of ~100. Founded in 1997, RDT is based in Basingstoke, Hampshire.

THE BIG PICTURE….

The big picture

Emergency medical hardware should be flexible enough to evolve with the ever-changing demands of pre-hospital care.  As well as focusing on providing safe patient care, prehospital health providers are increasingly seeing the need to  gather and utilise data more effectively, to measure patient outcomes and improve performance. The increasing demands are often being managed with static or limited resources and with technology that is isolated and non-connected.

The Tempus ALS is a platform that can evolve over time as the requirements and needs of services change. It is a complete system that combines innovative hardware and powerful software to expand the prehospital scope of care wider than ever before.

Its flexible deployment enables emergency medical providers to improve their workflow and positively impact safe patient outcomes with wider clinical, operational and financial advantages delivered to organizations.

If you would like to understand how we can help you drive clinical decision support and better resource utilisation, please come and visit us at two up and coming conferences:

19th & 20th September 2018 at the Emergency Services Show: Birmingham NEC, Hall 5, Stand #G47

20th, 21st & 22nd September at ERC: Bologna, Stand #F2

About RDT, a Philips Company:

Since being founded over 20 years ago, Remote Diagnostic Technologies (RDT) have been following a structured and impressive customer focused growth trajectory with its Tempus portfolio.  Following acquisition earlier this year by Philips Healthcare, it is abundantly clear that this is only set to continue. As an integrated business unit, RDT are taking the next step towards growth through combining their unique and nimble approach to R&D whilst leveraging the assets and infrastructure of Philips to accelerate global market reach.

Published 13th September, 2018

RDT Acquired by Philips Healthcare

Today we become: RDT a Philips Company.

We are thrilled and proud to be able to share the news today that, RDT has been wholly acquired by Philips Healthcare. We will be joining the Therapeutic Care Business Group and will become an integrated Business Unit within this group. RDT will continue to be led by Graham Murphy and based in Basingstoke, UK. We are confident this partnership will help deliver our life-saving solutions to more emergency responders and positively impact more patients around the world. Read the press release here

Press release issued 13th June 2018, 0800 CET

We are ahead of the curve with GDPR

We are ahead of the curve with GDPR

Release date 24th May 2018

GDPR may be the ‘buzz word’ right now, however, the way in which we securely capture, transmit and share sensitive data has always been at the core of our business. Our customer-focused approach means that we are well ahead of the curve when it comes to GDPR and beyond.

All Tempus devices have been designed from the core to capture and securely communicate rich medical data sets. Real-time data is recorded by the Tempus at the point of care either automatically or manually. This is always encrypted and easily shared via authenticated, highly secure channels to medical professionals and clinicians before being stored in a secure encrypted database. All data collected can be de-identified on a scheduled basis, or in response to an individual request at anytime. Patient data is processed only as necessary to protect the vital interests of the patient to enhance the accuracy of medical care and support clinical decisions.

2018 will see the launch of Corsium Suite. This will take our telemedicine capabilities to new levels, enabling unparalleled levels of data to be captured and shared. Real-time two way communication can be viewed and interacted with from any device via a secure web browser. This will deliver benefits on many levels for healthcare professionals and their patients:

Meet increasing demand

• Connect patients & clinicians for better on-scene decision making
• Reduce unnecessary conveyance
• Transport to specialised or primary care

Reduce transfer & handover times

• Key patient physiological and event data is real time
• Optimise management and reduce risk in ambulance queues
• Handover is electronic & seamless

Improve & measure quality of care

• Always get all data which is event synchronised
• Dashboards & over the air device management e.g. code data
• Drive process improvement & clinical governance

Improve workforce well-being

• Ergonomic & human factors advantages
• Building engagement across teams – feeling listened to
• Empowerment & support with clinical decision making

For more information please contact our team to be put in contact with a local representative.

About Remote Diagnostic Technologies Ltd:

RDT is a fast growing and customer focused, high-technology medical device business. We specialise in the design, manufacture, sales, marketing and worldwide distribution of best-in-class monitoring and resuscitation solutions. RDT are acutely focused on the prehospital market and continuously innovate to evolve our technologies, offering our customers unparalleled capabilities. Data & communications is core to all we do. With success success on a global scale, we serve an International customer base – driven and supported by a team of ~100. Founded in 1997, RDT is based in Basingstoke, Hampshire.

www.rdtltd.com

RDT announces 510(k) FDA Clearance for Tempus Technology

RDT announces 510(k) FDA Clearance for Tempus Technology

Release date 23rd January 2018

Remote Diagnostic Technologies (RDT) are pleased to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the integrated printer configuration of the Tempus Pro. This configuration of Tempus Pro enables a user to print medical records such as ECG strips on-demand.

Tempus Pro is rapidly becoming the monitor of choice for many NATO militaries around the globe. This configuration of the device is another example of RDT’s progress and commitment to continuously innovate and offer best-in-class technology for prehospital care.

RDT’s success story is set to continue. In the past 4 years, the business has trebled in size. In the past 2 years, it has doubled. Revenue is up 60% in the past year. Business is set to double again in the next 2 years.

About Remote Diagnostic Technologies Ltd:

RDT is a fast growing and customer focused, high-technology medical device business. We specialise in the design, manufacture, sales, marketing and worldwide distribution of best-in-class monitoring and resuscitation solutions. RDT are acutely focused on the prehospital market and continuously innovate to evolve our technologies, offering our customers unparalleled capabilities. Data & communications is core to all we do. With success success on a global scale, we serve an International customer base – driven and supported by a team of ~100. Founded in 1997, RDT is based in Basingstoke, Hampshire.

www.rdtltd.com

Tempus Pro used for latest Astronaut Recovery

Astronaut Paolo Nespoli’s recovery monitored with Tempus Pro

Release date 15th December 2017

As part of RDT’s collaboration within the ARTES Integrated Applications Programme of the European Space Agency, our Tempus technology has been used during their latest Astronaut recovery, in extremely harsh conditions. Space travel can place enormous pressure on the body and accurate monitoring of vital signs is fundamental during re-acclimatisation once back on earth.

Following copy courtesy of ESA – Stephane Corvaja, 2017*

ESA astronaut Paolo Nespoli and his colleagues Randy Bresnik of NASA and Sergei Ryazansky of Roscosmos returned to Earth from the International Space Station on 14 December in their Soyuz MS-05 spacecraft landing at 08:37 GMT.

The ride home from the International Space Station saw the trio brake from 28 800 km/h to a standstill at touchdown in barely three hours.

Paolo completed more than 60 experiments during his ‘VITA’ mission, which stands for Vitality, Innovation, Technology and Ability.

His body was itself an arena for research: his eyes, headaches, sleeping patterns and eating habits were monitored to learn more about how humans adapt to life in space. Temperature recordings, muscle exercises and plenty of blood and saliva samples will add to the picture and prepare humans for missions further from Earth.

*Source: http://www.esa.int/spaceinimages/Images/2017/12/Paolo_Nespoli_back_on_Earth4

RDT’s TEMPUS Pro used by the European Space Agency

RDT’s Tempus Proused at an astronaut landing

Remote Diagnostics Technologies (RDT), the high-tech medical device business focused on vital signs monitoring and telemedicine in the pre-hospital care space, is delighted to report that the Space Medicine Office of the European Space Agency (ESA) recently performed an operational evaluation of the Company’s Tempus Pro Monitor (Tempus Pro) during French Astronaut, Thomas Pesquet’s, flight and landing aboard a Soyuz 49S spacecraft as he returned from a six month stay on the International Space Station.

ESA performed a number of tests on the Tempus Pro as it transmitted real-time medical data including patient vitals, medical events and medications administered, as well as ultrasound images, videos, pictures and voice.

ESA concluded that the result of the test was positive, including that use of the monitor was easy in the real operational environment and it allowed fast and easy medical event logging, assessment, intervention and medication tracking.

RDT looks forward to continued collaboration with the ESA as it looks to develop its customer base in the aerospace industry.

Dr. Sergi Vaquer, Flight Surgeon at the European Space Agency commented: “The Tempus Pro was very easy to use in our challenging operational environment and allowed us fast and easy medical event logging and tracking. The monitor is small, light and robust enough to allow our medical professionals to work unimpeded by the equipment.”

Arnaud Runge, project manager at the European Space Agency for the Tempus pro and ALS commented: “We are pleased that the Tempus Pro, developed with the support of ESA’s ARTES applications programme, could be used at an astronaut landing. This is a demanding operational situation and proves the high performing capabilities of this product.”

Graham Murphy, CEO of RDT commented: “We have collaborated with the ESA over a number of years. We are delighted that our continued relationship has resulted in the implementation of our technology during a mission to monitor and assess the wellbeing of astronauts. We look forward to continued partnership”

About RDT
RDT specialise in the design and manufacture of medical devices, including pre-hospital care vital signs monitors.
Specialist technologies include compact and highly integrated vital signs monitors for both medical professional and non-medically trained users, as well as intermittent users.
The award-winning Tempus system provides innovative, easy to use and reliable medical device solutions to help manage medical incidents for the military, civilian pre-hospital care market and other remote and challenging locations.

RDT’s Tempus Pro procured by Norwegian Military

Norwegian Military procures RDT’s Tempus Pro

Remote Diagnostics Technologies (RDT) is delighted to report that in partnership with PHC Nordic, they have entered a contract with the NATO Support & Procurement Agency to provide Tempus Pro medical monitors for use by a NATO nation. Based on the terms of the contract which was placed under the NATO Logistics Stock Exchange the Tempus Pro and accessories will be provided to the customer.

The Norwegian Military have been using the Company’s Tempus Pro medical monitors for several years. Now, they are advancing their capabilities using products and services across RDT’s technological platform. Importantly, they will be taking a lead in utilising the sophisticated telemedicine functionality of the device to extract data from various locations, including battlefields, helicopters and remote environments and sharing the data with trusted medical support. Telemedicine is the new and cutting-edge element of military pre- hospital care and ensures that troops on the ground are diagnosed and cared for as fast as possible with the best equipment and technology in remote areas of the world.

New units will be rolled out across the Norwegian tri-services with plans for ongoing deployment, and development to aid interoperability between forces, both Norwegian and other NATO forces.

RDT’s relationship with the Norwegian Military has seen trials and evaluations of equipment that has been designed specifically for use in challenging and remote environments, settings in which Norwegian troops see themselves in every day. The ground-breaking technology is compact, easy to use and the reliable, allowing for high quality care to be administered in the most demanding conditions.

This contract win, joins several contracts secured by RDT with militaries around the world including the UK, US, Australia, Canada, Spain and others.

With customers all over the world, across numerous markets including aviation, shipping, military and mining, RDT is a leader in the global telemedicine in the pre-hospital care space.

Christer Höög, Director, PHC Nordic, commented: “PHC Nordic is proud to be a partner in this important contract that will help the Norwegian Armed services to improve care regardless of the location via the Telemedicine capability provided with the Tempus Pro

Graham Murphy, Chief Executive, RDT, commented: “This exciting contract brings to fruition several years of hard work between RDT, PHC Nordic and the Norwegian military. We are delighted to be able to offer the best in class solution that supports military personnel in all terrains and environments. Our product has proven to be the most effective, lightest and with all the functionality that the military requires.”

RDT wins £14 million MOD medical monitor contract

RDT wins £14 million medical monitor contract

The Ministry of Defence has awarded a £14 million tri-service contract for medical monitors to Hampshire-based company RDT, a world-leader and fast-growing specialist in pre-hospital care solutions. The new agreement will see the delivery of around 900 compact, easy-to-use and reliable vital signs Tempus Pro monitors, which will enable the UK military to manage medical incidents in the remote and challenging locations in which they regularly operate. Tempus Pro uniquely consolidates several functions and multiple devices into one system, ensuring that Armed Forces medical personnel can provide the best quality of care possible to critically injured service men and women in very challenging environments. Tempus Pro monitors will be deployed on medical evacuation vehicles and aircraft, battalion aid stations, hospital ships, field hospitals and in far forward locations by special operations teams.

This award is the latest in a long line of successes for RDT, which has achieved 60 % growth in the last 12 months. RDT is a significant exporter, generating more than 60 % of its revenue from international sales. Maria Miller, MP for Basingstoke, said: “RDT is a ground-breaking company and its success in securing this contract demonstrates the strong entrepreneurial, engineering and technological talent available in Basingstoke. This talent pool supports a thriving hub of high growth, high tech businesses in the town. The contract will sustain over 60 jobs at RDT’s local facility and has helped in the creation of 20 new roles. I congratulate Graham and his team on this tremendous achievement.”

The MOD selected RDT’s Tempus Pro monitoring system after an extensive evaluation programme that highlighted how this very small and robust monitoring platform delivers significantly more capability for British troops than existing solutions. Over the next five years, the MOD will replace all existing monitors with the Tempus Pro system. RDT has already delivered 444 monitors to the Armed Forces.

Minister for Defence Procurement Harriett Baldwin said: “Our Armed Forces serve with incredible commitment and bravery, and the new Tempus Pro monitor will ensure that they will receive the best possible care and treatment should they be wounded or taken ill on operations. Backed by our rising defence budget and our £178 billion equipment plan, our investment in these cutting-edge medical monitors demonstrates how we are working with our NATO allies to provide lifesaving equipment to our frontline personnel.”

Before awarding the contract, the Defence Equipment and Support organisation (DE&S) conducted an intensive year-long, multi-discipline monitor evaluation process that saw the system deployed and rigorously tested in extremely harsh and challenging locations. Traditionally, several various monitor types have had to be used at different levels of care in the patient pathway. Thanks to the modular and flexible nature of RDT’s Tempus Pro system, the UK MOD is now able to standardise on one monitor to provide streamlined medical support and critical patient care information from the battlefield onwards. This means the Record of Care of all sick and injured patients can easily move with them as they progress through different levels of care, and ultimately be saved into their permanent patient record. A single monitoring solution has been an objective of the UK military for some time. It is only possible because of the forward-thinking and innovative way in which RDT has approached the development of its medical monitoring technology.

Chief Executive Officer of the DE&S, Tony Douglas, said: “This state-of-the-art piece of equipment shows how we are delivering proven, world-leading equipment to our Armed Forces. The Tempus Pro monitor is a step forward in innovation and safety, demonstrating how we are committed to improving the medical care received by those keeping our country safe. This deal also highlights DE&S’ strong, collaborative partnership with industry, benefitting both our Armed Forces and the wider UK economy by sustaining around 60 UK jobs.”

Graham Murphy, RDT CEO, added: “We are incredibly proud to be providing the Tempus Pro to our Armed Forces, who do such important work to keep us all safe. One of the reasons the Tempus Pro is being adopted by the UK and many other NATO militaries is because of its unique ability to be enhanced in the field as new technologies emerge or needs evolve. The world is an ever-changing place and this flexibility is important to all our customers. To that end, RDT has an exciting set of new features in development to which the MOD will have full access as they become available.”

About RDT
RDT specialise in the design, manufacture, sales, marketing and worldwide distribution of medical devices, including pre-hospital care vital signs monitors.
Specialist technologies include compact and highly integrated vital signs monitors for both medical professional and non-medically trained users, as well as intermittent users.
The award-winning Tempus system provides innovative, easy to use and reliable medical device solutions to help manage medical incidents for the military, civilian pre-hospital care market and other remote and challenging locations.